Browsing Tag
Gonal-f
1 post
EMD Serono acquires two PostEra AI-designed fertility drug programmes
EMD Serono has acquired two preclinical fertility programmes created using PostEra’s Proton AI platform, giving Merck KGaA control of oral FSHR and LHCGR agonist candidates that could challenge injectable treatment models if clinical development succeeds.
September 10, 2026